Font Size Smaller Font Size
Larger Font Size
Latest Press Releases
-
October 19, 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
-
October 19, 2017
Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting
-
October 16, 2017
Results from Phase 2 Studies of Oral Ozanimod in Crohn's Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017
-
October 2, 2017
Celgene Corporation to Announce Third Quarter 2017 Results on October 26, 2017; Will Host an Investor Webcast Event from the MSParis2017-7th Joint ECTRIMS - ACTRIMS Meeting on October 28, 2017
-
September 8, 2017
Data Presented at ESMO 2017 Further Evaluate Role of ABRAXANE® for Patients with Historically Challenging Cancers
No results found.